Skip to main content
Erschienen in: Medical Molecular Morphology 2/2017

22.08.2015 | Case Report

A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells

verfasst von: Shogo Tajima, Ichiro Namiki, Kenji Koda

Erschienen in: Medical Molecular Morphology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The predominance of clear cells in mucoepidermoid carcinomas (MEC) is rare, and cases in which this occurs are termed clear cell variants of MEC. We present a case of a 70-year-old woman complaining of a right buccal mucosal mass, which had increased in size over 1 year. Histological examination revealed the mass to be composed predominantly of clear tumor cells, with mucin-containing cells and intermediate cell-like cells. Immunohistochemistry indicated that the tumor was positive for CK5/6 and p63, but negative for myoepithelial markers such as S-100 protein, αSMA, and calponin. These findings ruled out the possibility of a clear cell myoepithelial carcinoma, which is the most frequently observed type of salivary carcinoma composed predominantly of clear cells. However, it is difficult to distinguish between clear cell variants of MEC and hyalinizing clear cell carcinoma. Therefore, we performed fluorescence in situ hybridization to determine whether MAML2 rearrangement had occurred in this mass. Direct sequencing of the RT-PCR product demonstrated CRTC1-MAML2 fusion between exon 1 of CRTC1 and exon 2 of MAML2. Thus, the diagnosis of clear cell variant of MEC was confirmed. This is the first report of CRTC1-MAML2 fusion gene detection in a clear cell variant of MEC.
Literatur
1.
Zurück zum Zitat Goode RK, Auclair PL, Ellis GL (1998) Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82(7):1217–1224CrossRefPubMed Goode RK, Auclair PL, Ellis GL (1998) Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82(7):1217–1224CrossRefPubMed
2.
Zurück zum Zitat Guzzo M, Andreola S, Sirizzotti G, Cantu G (2002) Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 9(7):688–695CrossRefPubMed Guzzo M, Andreola S, Sirizzotti G, Cantu G (2002) Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 9(7):688–695CrossRefPubMed
5.
Zurück zum Zitat Clauditz TS, Gontarewicz A, Wang CJ, Munscher A, Laban S, Tsourlakis MC, Knecht R, Sauter G, Wilczak W (2012) 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma. Diagn Mol Pathol 21(3):134–137. doi:10.1097/PDM.0b013e318255552c CrossRefPubMed Clauditz TS, Gontarewicz A, Wang CJ, Munscher A, Laban S, Tsourlakis MC, Knecht R, Sauter G, Wilczak W (2012) 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma. Diagn Mol Pathol 21(3):134–137. doi:10.​1097/​PDM.​0b013e318255552c​ CrossRefPubMed
6.
Zurück zum Zitat Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Makitie A, Grenman R, Mark J, Stenman G (2006) Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45(5):470–481. doi:10.1002/gcc.20306 CrossRefPubMed Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Makitie A, Grenman R, Mark J, Stenman G (2006) Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45(5):470–481. doi:10.​1002/​gcc.​20306 CrossRefPubMed
8.
9.
Zurück zum Zitat Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H (2009) Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol 22(12):1575–1581. doi:10.1038/modpathol.2009.126 CrossRefPubMed Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H (2009) Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol 22(12):1575–1581. doi:10.​1038/​modpathol.​2009.​126 CrossRefPubMed
11.
Zurück zum Zitat Skalova A, Weinreb I, Hyrcza M, Simpson RH, Laco J, Agaimy A, Vazmitel M, Majewska H, Vanecek T, Talarcik P, Manajlovic S, Losito SN, Steiner P, Klimkova A, Michal M (2015) Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol 39(3):338–348. doi:10.1097/pas.0000000000000364 CrossRefPubMed Skalova A, Weinreb I, Hyrcza M, Simpson RH, Laco J, Agaimy A, Vazmitel M, Majewska H, Vanecek T, Talarcik P, Manajlovic S, Losito SN, Steiner P, Klimkova A, Michal M (2015) Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol 39(3):338–348. doi:10.​1097/​pas.​0000000000000364​ CrossRefPubMed
13.
Zurück zum Zitat Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, Perez-Ordonez B, Have C, Asa SL, Leong IT, Bradley G, Klieb H, Weinreb I (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50(7):559–570. doi:10.1002/gcc.20881 CrossRefPubMed Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, Perez-Ordonez B, Have C, Asa SL, Leong IT, Bradley G, Klieb H, Weinreb I (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50(7):559–570. doi:10.​1002/​gcc.​20881 CrossRefPubMed
14.
Zurück zum Zitat do Prado RF, Lima CF, Pontes HA, Almeida JD, Cabral LA, Carvalho YR (2007) Calcifications in a clear cell mucoepidermoid carcinoma: a case report with histological and immunohistochemical findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(5):e40–e44. doi:10.1016/j.tripleo.2007.06.001 CrossRefPubMed do Prado RF, Lima CF, Pontes HA, Almeida JD, Cabral LA, Carvalho YR (2007) Calcifications in a clear cell mucoepidermoid carcinoma: a case report with histological and immunohistochemical findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(5):e40–e44. doi:10.​1016/​j.​tripleo.​2007.​06.​001 CrossRefPubMed
17.
Zurück zum Zitat Jee KJ, Persson M, Heikinheimo K, Passador-Santos F, Aro K, Knuutila S, Odell EW, Makitie A, Sundelin K, Stenman G, Leivo I (2013) Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol 26(2):213–222. doi:10.1038/modpathol.2012.154 CrossRefPubMed Jee KJ, Persson M, Heikinheimo K, Passador-Santos F, Aro K, Knuutila S, Odell EW, Makitie A, Sundelin K, Stenman G, Leivo I (2013) Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol 26(2):213–222. doi:10.​1038/​modpathol.​2012.​154 CrossRefPubMed
18.
Zurück zum Zitat Verdorfer I, Fehr A, Bullerdiek J, Scholz N, Brunner A, Krugmann J, Hager M, Haufe H, Mikuz G, Scholtz A (2009) Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland. Oncol Rep 22(2):305–311PubMed Verdorfer I, Fehr A, Bullerdiek J, Scholz N, Brunner A, Krugmann J, Hager M, Haufe H, Mikuz G, Scholtz A (2009) Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland. Oncol Rep 22(2):305–311PubMed
Metadaten
Titel
A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells
verfasst von
Shogo Tajima
Ichiro Namiki
Kenji Koda
Publikationsdatum
22.08.2015
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 2/2017
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-015-0120-5

Weitere Artikel der Ausgabe 2/2017

Medical Molecular Morphology 2/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie